|
Demonstration Project T2D Implementation |
Type 2 Diabetes - Demonstration Project |
Vanderbilt University |
Case, Control |
|
|
100%, 100% |
|
|
Anxiety - CCHMC |
Anxiety algorithm |
Cincinnati Children's Hospital Medical Center |
Case, Control |
|
|
100%, 100% |
|
|
Validation of Asthma algorithm - Geisinger |
Asthma |
Geisinger |
Case, Control |
10 |
10 |
100%, 100% |
|
|
Demonstration Project Crohn's Disease Implementation |
Crohn's Disease - Demonstration Project |
Vanderbilt University |
Case, Control |
|
|
100%, 100% |
|
|
Group Health Implementation of Atopic Dermatitis Algorithm |
Atopic Dermatitis Algorithm |
Group Health Cooperative |
Case, Control |
206 |
207 |
100%, 100% |
100% |
|
CHOP case-post operative implementation |
Post-event Pain algorithm |
The Children's Hospital of Philadelphia |
Case Only |
2 |
|
100% |
|
|
KPWA/UW (primary site) implementation |
Depression |
KPWA/UW |
Case, Control |
1,999 |
4,268 |
100%, 100% |
100%, 100% |
|
VUMC ACEi cough implementation |
ACE Inhibitor (ACE-I) induced cough |
Vanderbilt University |
Case, Control |
|
|
100%, 100% |
96% |
|
Statins and MACE Marshfield Implementation |
Statins and MACE |
Marshfield Clinic Research Foundation |
Case Only |
50 |
|
100% |
100% |
|
Validation of ACEi-induced cough algorithm |
ACE Inhibitor (ACE-I) induced cough |
Mayo Clinic |
Case, Control |
|
|
100%, 96% |
|
|
Marshfield Hearing loss validation |
Hearing Loss |
Marshfield Clinic Research Foundation |
Case, Control |
25 |
25 |
100%, 100% |
|
|
Vanderbilt implementation |
Clostridium Difficile Colitis |
|
Case, Control |
|
|
100%, 100% |
|
|
Marshfield implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Marshfield Clinic Research Foundation |
Case, Control |
71 |
435 |
100%, 100% |
100% |
|
NU ACE Inhibitor (ACE-I) induced cough implementation |
ACE Inhibitor (ACE-I) induced cough |
Northwestern University The Feinberg School of Medicine |
Case, Control |
|
|
100%, 98% |
|
|
Marshfield AAA implementation |
Abdominal Aortic Aneurysm ( AAA ) |
Marshfield Clinic Research Foundation |
Case, Control |
25 |
22 |
100%, 100% |
|
|
Mayo FH Implementation |
Electronic Health Record-based Phenotyping Algorithm for Familial Hypercholesterolemia |
Mayo Clinic |
Case, Control |
58 |
42 |
100%, 98% |
100%, 100% |
|
caMRSA chart verification |
caMRSA |
GHRI/UW |
Case, Control |
72 |
2,310 |
100%, 100% |
100%, 100% |
|
Marshfield C-diff implementation |
Clostridium Difficile Colitis |
Marshfield Clinic Research Foundation |
Case, Control |
21 |
10 |
100%, 100% |
|
|
Marshfield ACE-I cough implentation |
ACE Inhibitor (ACE-I) induced cough |
Marshfield Clinic Research Foundation |
Case, Control |
25 |
25 |
100%, 96% |
|
|
GH/UW Verification |
Gastroesophageal Reflux Disease (GERD) Phenotype Algorithm |
Group Health and University of Washington |
Case, Control |
479 |
319 |
100%, 100% |
100%, 100% |
|
Implementation For Phase 3 eMERGE |
Electronic Health Record-based Phenotyping Algorithm for Familial Hypercholesterolemia |
Geisinger |
Case, Control |
25 |
25 |
100%, 96% |
|
|
Marshfield implementation |
caMRSA |
Marshfield Clinic Research Foundation |
Case, Control |
|
|
100%, 100% |
100%, 100% |
|
Marshfield Implementation 2 |
CAAD (Carotid Artery Atherosclerosis Disease) |
Marshfield Clinic Research Foundation |
Case, Control |
193 |
4,170 |
100%, 100% |
|
|
Geisinger Impl |
Colorectal Cancer (CRC) |
Geisinger |
Case, Control |
25 |
25 |
100%, 100% |
|
|
Geisinger c.Diff eMERGE3 Implementation |
Clostridium Difficile Colitis |
Geisinger |
Case, Control |
20 |
20 |
100%, 100% |
100%, 100% |
